GPC3 and liver cancer: In addition to GPC3, most gene signatures used in our diagnosis model have also been confirmed in liver cancer (Wu et al., 2000; Chen et al., 2014; Ji et al., 2014; Li et al., 2015; Zhao et al., 2019), and the expression trends of those genes are consistent with our DP.eHCC model.